These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6756728)

  • 1. Insulin antibodies induced by bovine insulin therapy.
    Reeves WG; Kelly U
    Clin Exp Immunol; 1982 Oct; 50(1):163-70. PubMed ID: 6756728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-peptide antibodies induced by bovine insulin therapy.
    Reeves WG; Douglas CA
    Clin Exp Immunol; 1982 Oct; 50(1):171-7. PubMed ID: 6756729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating IgG antibody to protamine in patients treated with protamine-insulins.
    Kurtz AB; Gray RS; Markanday S; Nabarro JD
    Diabetologia; 1983 Oct; 25(4):322-4. PubMed ID: 6196244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human insulin.
    Roberts RJ
    Iowa Med; 1984 Mar; 74(3):116-8. PubMed ID: 6373658
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type].
    Andreani D; Iavicoli M; Colletti A; Menzinger G
    Folia Endocrinol; 1972 Dec; 25(6):516-39. PubMed ID: 4581824
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic response to mono-component insulin in newly diagnosed diabetic patients.
    Devlin JG; Parameswaran V
    Ir Med J; 1975 Jun; 68(12):301-5. PubMed ID: 1140940
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin antibodies and clinical complications in diabetics treated for five years with lente or sulfated insulin.
    Little JA; Lee R; Sebriakova M; Csima A
    Diabetes; 1977 Oct; 26(10):980-8. PubMed ID: 561729
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunogenicity of insulin of various origins.
    Reeves WG
    Neth J Med; 1985; 28 Suppl 1():43-6. PubMed ID: 3892338
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunogenicity of MC Lente Novo insulin].
    Rogala H; Lawecki J; Czyzyk A
    Pol Arch Med Wewn; 1986 Sep; 76(3):172-6. PubMed ID: 3554163
    [No Abstract]   [Full Text] [Related]  

  • 10. The immunogenicity of insulin preparations.
    Chance RE; Root MA; Galloway JA
    Acta Endocrinol Suppl (Copenh); 1976; 205():185-98. PubMed ID: 793278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. U-500 insulin in the treatment of antibody-mediated insulin resistance.
    Nathan DM; Axelrod L; Flier JS; Carr DB
    Ann Intern Med; 1981 May; 94(5):653-6. PubMed ID: 7015948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proinsulin and a-component antibodies in diabetics treated with monocomponent and conventional insulin].
    Gamba S; Barbero PL; Bollati C; Castellazzi R; D'Adda A; Bruni B
    Minerva Dietol Gastroenterol; 1979; 25(3):309-14. PubMed ID: 400003
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin antibody formation during long-term treatment with monocomponent and monospecies insulin.
    Piers DA; Sluiter WJ; Reitsma WD; Doorenbos H
    Neth J Med; 1974; 17(4-5):234-8. PubMed ID: 4465730
    [No Abstract]   [Full Text] [Related]  

  • 14. Bovine and human NPH insulins as T cell immunogens.
    Gregory R; Tattersall RB
    Diabetes Res Clin Pract; 1993 May; 20(2):139-46. PubMed ID: 8375267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proceedings: Formation of anti-insulin antibodies IgG in diabetic patients treated with conventional insulin monocomposed or monospecific].
    Weber HU; Sourisseau D; Zahnd GR
    Helv Med Acta; 1974 May; 37(5-6):367. PubMed ID: 4410557
    [No Abstract]   [Full Text] [Related]  

  • 16. High and low affinity insulin antibodies.
    Kerp L; Kasemir H
    Acta Endocrinol Suppl (Copenh); 1976; 205():211-22. PubMed ID: 1087091
    [No Abstract]   [Full Text] [Related]  

  • 17. Heterogeneity and specificity of human anti-insulin antibodies determined by isoelectric focusing.
    Thomas JW; Virta VJ; Nell LJ
    J Immunol; 1985 Feb; 134(2):1048-52. PubMed ID: 3880786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating insulin antibodies during therapy with highly purified neutrally buffered insulins including desphe insulins. Report of a prospective study with 40 cases.
    Kühnau J; Rüdiger H; Goetz K
    Exp Clin Endocrinol; 1984 Apr; 83(2):161-7. PubMed ID: 6373318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-bovine or porcine-insulin antibody].
    Kobayashi M; Ishibashi O
    Nihon Rinsho; 1990 Feb; 48 Suppl():841-3. PubMed ID: 2192166
    [No Abstract]   [Full Text] [Related]  

  • 20. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
    Anderson OO
    Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.